Wiegers, E, Steyerberg, E, Rajpar, A, Paliwal, P, Kanani, K, Kroon, HA, Dananberg, J, Cornblath, D, Willison, H, Kim, M, Gorson, K, Querol, L, Hartung, HP, Islam, Z, van Doorn, PA, Jacobs, B. Comparative Effectiveness In IGOS: ANX005 Versus Intravenous Immunoglobulin or Plasma Exchange For Guillain-Barre Syndrome. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Dymm, B, Van den Bergh, P, London, Z, Lewis, R, Querol, L, Harbo, T, Allen, J, Hadden, R, Van Doorn, PA. Development and Validation of a Digital Tool to Simplify Use of Guidelines For CIDP Diagnosis. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Rajpar, A, Wiegers, E, Thomma, R, van Tilburg, S, Plomp, L, Sammelius, L, van Rijs, W, Harbo, T, Hartung, HP, Islam, Z, Lunn, M, Querol, L, Huizinga, R, Jacobs, B. Serum Neurofilament Light Chain in The International GBS Outcome Study: Predicting Disease Course and Outcome. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Querol, L, Peric, S, Cadour, S, Rigby, S, Van de Walle, I, Persson, E, Vujcic, M, Van de Steen, O, Mashchenko, O, Van Hoomissen, I, Allen, J, Katzberg, H, Kuwabara, S, Stettner, M, Rinaldi, S, van der Pol, WL. Empasiprubart Versus Intravenous Immunoglobulin in Multifocal Motor Neuropathy Phase 3 Study Design: EMPASSION. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Querol, L, Lewis, R, Sommer, C, Bromberg, M, Barrera-Sierra, S, Arvin-Berod, C, Nisbet, P, Gelinas, D, Guptill, J, Wood, J. Management of Patients With Multifocal Motor Neuropathy: A Global Quantitative Survey of Neurologists. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

van der Pol, WL, Krijgsman, D, Querol, L, Persson, E, Rutjens, S, Cadour, S, Dijkxhoorn, K, Bloemenkamp, LM, de Zeeuw, E, Vujcic, M, Van de Walle, I. Empasiprubart in Multifocal Motor Neuropathy: Exploratory Analyses of the Phase 2 ARDA Study. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Eric, CT, Querol, L, Rodés, M, Thirugnanam, UN. Test Database and International Collaboration For Improving Peripheral Neurology in Resource Limited Settings. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Allen, J, Lin, J, Stettner, M, Guptill, J, Istas, G, De Roeck, A, Kuwabara, S, Pinter, GL, Querol, L, Suresh, N, Karam, C, Skripuletz, T, Rinaldi, S, Echaniz-Laguna, A, Hewamadduma, C, Van Hoorick, B, Yamasaki, R, van Doorn, P, Lewis, R. Impact of Prior Chronic Inflammatory Demyelinating Polyneuropathy Treatments in the ADHERE Trial: Post Hoc Analyses. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Vegezzi, E, Quartesan, I, Facchini, S, Curro, R, Mussinelli, R, Palladini, G, Milani, P, Nuvolone, M, Anan, I, Todorova, A, Tournev, I, Hegenbart, U, Schönland, S, Siepen, F, Gillmore, JD, Razvi, Y, Rowczenio, D, Coelho, T, Lemos, C, Alves-Ferreira, M, Mandich, P, Conceicao, I, Marques, W Jr, Tomaselli, P, Alves, G, Planté-Bordeneuve, V, Perrain, V, Hahn, K, Reilly, MM, Houlden, H, Pons, CC, Morales, M, Fabrizi, GM, Tagliapietra, M, Knoll, K, Trenkwalder, T, Cappelli, F, Argirò, A, Arregui, ALD, Agudo, PI, Torrón, RF, Arana-Achaga, X, Goena-Vives, C, Martinez, MLP, Aguirre, MA, Saez, M, Cisneros-Barroso, E, Luigetti, M, Berk, J, Prokaeva, T, Sekijima, Y, Yoshinaga, T, Garcia, SK, Théaudin, M, Guaraldi, P, Gragera, A, Rojas-García, R, Carbayo-Viejo, A, Gonzalez-Duarte, A, Cardenas-Soto, K, Menao, S, Kleopa, K, Zamba-Papanicolaou, E, Christodoulou, C, Waddington-Cruz, M, Foguel, D, Russo, M, Mazzeo, A, Sevilla, T, Sivera, R, Tasaki, M, Ueda, M, Reisin, R, Cejas, LL, Petit, C, Di Stefano, V, Antonini, G, Leonardi, L, Sanchez-Tejerina, D, Manganelli, F, Tozza, S, Pareyson, D, Fenu, S, Briani, C, Salvalaggio, A, Obici, L, Cortese, A. Genetic Modifiers in Hereditary and Wild-Type TTR Amyloidosis: Update on Genome-wide Association Study. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(3)DOI:. PMID:. IF:3.200(Q2/4D).

Querol, L, Harbo, T, Peric, S, Hussain, Y, Cadour, S, van de Walle, I, Persson, E, Vujcic, M, van de Steen, O, Allen, J, Orazio, EN, Attarian, S, Karam, C, Katzberg, H, Stettner, M, Rinaldi, S, van der Pol, W. Safety and efficacy data from the phase 2 ARDA study of empasiprubart in multifocal motor neuropathy. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Querol, L, Lewis, RA, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Auwarter, K, Lu, Y, Alonso, MA, Atassi, N, Hughes, RAC. Safety and efficacy of riliprubart in chronic inflammatory demyelinating polyneuropathy: 76-week phase 2 trial results. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Rinaldi, S, Allen, J, Lin, J, Stettner, M, Merkies, I, Guptill, J, Hewamadduma, C, Istas, G, De Roeck, A, Kuwabara, S, Lauria, G, Querol, L, Suresh, N, Karam, C, Skripuletz, T, Echaniz-Laguna, A, Van Hoorick, B, Yamasaki, R, Lewis, R, van Doorn, P. Effect of efgartigimod PH20 SC on lower limb function in chronic inflammatory demyelinating polyneuropathy in ADHERE. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Collet-Vidiella, R, Aguilar, LM, Lleix , C, Caballero-Avila, M, Illa, CT, Go i, EP, Llarch, P, Lluci -Carol, L, Tous, MS, Casasnovas, C, Guti rrez-Guti rrez, G, Fern ndez, JP, Carbayo, A, Gallardo, E, Vesperinas, A, Llanso, L, Fern ndez-Cadenas, I, Querol, L. Proteomic profiling of Guillain-Barre Syndrome using aptamers: Identifying and Validating Potential Biomarkers. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

De Lorenzo, A, Moretti, G, Bertini, A, Collet-Vidiella, R, Fasolino, A, Fortanier, E, Hadden, R, Islam, B, Kleopa, K, Cejas, LL, Leonardi, L, Mira, V, Peric, S, Rajabally, Y, Sevilla, T, Tomaselli, P, Tozza, S, Pisciotta, C, Pareyson, D, Nobile-Orazio, E, Doneddu, P. Chat-GPT-4o in diagnosis and management of real-life polyneuropathy cases: Comparative analysis with neurologists. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Hernandez, EM, Maqueda, JC, Fonseca, E, Marco, C, Chico, J, Fernandez, JG, Llaurado, A, Cabello, J, del Pino, L, Izquierdo, C, Cortes, E, G llego, J, Ros, M, Cald , R, Pelayo, A, Vizcaino, CS, Hernandez, H, Alvarez, J, Simo, M, Dalmau, J, Bruna, J, Velasco, R. Immune checkpoint inhibitor-related myositis-myasthenia: A retrospective cohort study in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Lewis, RA, Querol, L, Hartung, HP, van Doorn, PA, Lin, J, Dionne, A, Attarian, S, Wallstroem, E, Lu, Y, Alonso, MA, Atassi, N, Hughes, AC. Efficacy of Riliprubart in chronic inflammatory demyelinating polyneuropathy: Phase 2 subgroup analyses. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Querol, L, Lewis, R, Sommer, C, Bromberg, M, Barrera-Sierra, S, Arvin-Berod, C, Nisbet, P, Gelinas, D, Guptill, J, Wood, J. Managing multifocal motor neuropathy: A survey of neurologists from Japan, Canada, and six European countries. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Reyes, V, Maurino, J, Armangu , T, Querol, L, Guti rrez-Guti rrez, G, Sotoca, J, Ares, A, Villaverde, R, Salas, E, D az-Abos, P, Cort s-Vicente, E, Gomez-Ballesteros, R, Ballesteros, J. Psychometric evaluation of resistance to change questionnaire: reluctance to adopt new treatments in myasthenia gravis. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Sacconi, S, Antozzi, C, Cortes-Vicente, E, Pascuzzi, R, Utsugisawa, K, Vissing, J, Vu, T, Bloemers, J, Grimson, F, Tarancon, T, Bril, V. Quality of life in patients with generalised myasthenia gravis receiving rozanolixizumab: Post hoc analysis of MycarinG. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).

Skripuletz, T, Allen, J, Rinaldi, S, Lauria, G, Querol, L, Magy, L, De Roeck, A, Van Hoorick, B, Hofman, E, Istas, G, Stettner, M, Lewis, R, van Doorn, P. Efgartigimod in pretreated patients with CIDP and progressive/relapsing or persistent disease activity. EUROPEAN JOURNAL OF NEUROLOGY. 2025; 32DOI:. PMID:. IF:3.900(Q1/3D).